Rehman, N.U.; Ullah, S.; Alam, T.; Halim, S.A.; Mohanta, T.K.; Khan, A.; Anwar, M.U.; Csuk, R.; Avula, S.K.; Al-Harrasi, A.
Discovery of New Boswellic Acid Hybrid 1H-1,2,3-Triazoles for Diabetic Management: In Vitro and In Silico Studies. Pharmaceuticals 2023, 16, 229.
https://doi.org/10.3390/ph16020229
AMA Style
Rehman NU, Ullah S, Alam T, Halim SA, Mohanta TK, Khan A, Anwar MU, Csuk R, Avula SK, Al-Harrasi A.
Discovery of New Boswellic Acid Hybrid 1H-1,2,3-Triazoles for Diabetic Management: In Vitro and In Silico Studies. Pharmaceuticals. 2023; 16(2):229.
https://doi.org/10.3390/ph16020229
Chicago/Turabian Style
Rehman, Najeeb Ur, Saeed Ullah, Tanveer Alam, Sobia Ahsan Halim, Tapan Kumar Mohanta, Ajmal Khan, Muhammad U. Anwar, René Csuk, Satya Kumar Avula, and Ahmed Al-Harrasi.
2023. "Discovery of New Boswellic Acid Hybrid 1H-1,2,3-Triazoles for Diabetic Management: In Vitro and In Silico Studies" Pharmaceuticals 16, no. 2: 229.
https://doi.org/10.3390/ph16020229
APA Style
Rehman, N. U., Ullah, S., Alam, T., Halim, S. A., Mohanta, T. K., Khan, A., Anwar, M. U., Csuk, R., Avula, S. K., & Al-Harrasi, A.
(2023). Discovery of New Boswellic Acid Hybrid 1H-1,2,3-Triazoles for Diabetic Management: In Vitro and In Silico Studies. Pharmaceuticals, 16(2), 229.
https://doi.org/10.3390/ph16020229